PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) and Autonomix Medical (NASDAQ:AMIX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, earnings and profitability.
Institutional & Insider Ownership
89.5% of PROCEPT BioRobotics shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 19.6% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares PROCEPT BioRobotics and Autonomix Medical’s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
PROCEPT BioRobotics | $136.19 million | 20.00 | -$105.90 million | ($2.24) | -23.65 |
Autonomix Medical | N/A | N/A | -$3.11 million | N/A | N/A |
Analyst Recommendations
This is a breakdown of recent ratings for PROCEPT BioRobotics and Autonomix Medical, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
PROCEPT BioRobotics | 0 | 0 | 6 | 0 | 3.00 |
Autonomix Medical | 0 | 0 | 0 | 0 | N/A |
PROCEPT BioRobotics currently has a consensus target price of $46.00, indicating a potential downside of 13.17%. Given PROCEPT BioRobotics’ higher possible upside, research analysts plainly believe PROCEPT BioRobotics is more favorable than Autonomix Medical.
Profitability
This table compares PROCEPT BioRobotics and Autonomix Medical’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
PROCEPT BioRobotics | -77.75% | -46.59% | -30.63% |
Autonomix Medical | N/A | N/A | N/A |
Summary
PROCEPT BioRobotics beats Autonomix Medical on 5 of the 9 factors compared between the two stocks.
About PROCEPT BioRobotics
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
About Autonomix Medical
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Receive News & Ratings for PROCEPT BioRobotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PROCEPT BioRobotics and related companies with MarketBeat.com's FREE daily email newsletter.